Wednesday, 13th of July, 2022 6 pm – 7:15 pm (CET)
GI bleeding is one of the greatest challenges for endoscopists and there is a variety of treatment options. Three independent randomized-controlled trials show high clinical success rates by using the OTSC for first-line treatment, clearly showing its superiority compared to former standard treatment.
If you want to know more, take part in this groundbreaking webinar on the most recent scientific data for hemostasis with the OTSC System.
We are very proud to have Prof. Lau, Prof. Jensen and Prof. Caca as speakers, which will present their results and answer your questions.
The session will take place on the 13th of July from 6:00 – 7:15 pm (CET) and is moderated by Dr. Latorre and Prof. Hochberger.
USA RCT of OTSC as initial treatment of severe UGI hemorrhage from peptic ulcers and Dieulafoy lesions
Prof. Dr. Dennis M. Jensen (Los Angeles, USA)
OTSC as first-line treatment of NVUGIB: European (German) multicenter RCT (STING-2)
Prof. Dr. Karel Caca (Ludwigsburg, Germany)
An Asia Pacific Multicenter RCT that compares OTSC to standardtreatment in patients with acute nonvariceal UGIB
Prof. Dr. James Lau (Hong Kong)
You can see the full agenda here: